Showing results (241-250 of 267) with videos related to
Sort By:
Pageof 27
Clinical Pharmacokinetics|October 7, 2017
Influence of Disease and Patient Characteristics on Daratumumab Exposure and Clinical Outcomes in Relapsed or Refractory Multiple MyelomaXiaoyu Yan, Pamela L Clemens, Thomas Puchalski, et al.Gastroenterology|June 19, 2017
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular FeaturesDaniela Sia, Yang Jiao, Iris Martinez-Quetglas, et al.Colloids and Surfaces. B, Biointerfaces|November 4, 2022
Graphene woven fabric-polydimethylsiloxane piezoresistive films for smart multi-stimuli responsesTran T Tung, Manh T Tran, Ana L C Pereira, et al.Nature Neuroscience|July 25, 2018
Epigenetic regulation of brain region-specific microglia clearance activityPinar Ayata, Ana Badimon, Hayley J Strasburger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Ofatumumab as single-agent CD20 immunotherapy in fludarabine-refractory chronic lymphocytic leukemiaWilliam G Wierda, Thomas J Kipps, Jirí Mayer, et al.Frontiers in Genetics|January 20, 2022
Open Problems in Extracellular RNA Data Analysis: Insights From an ERCC Online WorkshopRoger P Alexander, Robert R Kitchen, Juan Pablo Tosar, et al.Analytical Chemistry|March 14, 2023
International Interlaboratory Comparison of Thermogravimetric Analysis of Graphene-Related Two-Dimensional MaterialsPei Lay Yap, Farzaneh Farivar, Åsa K Jämting, et al.Plos Genetics|June 24, 2021
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinomaAmanda J Craig, Teresa Garcia-Lezana, Marina Ruiz de Galarreta, et al.Nature Communications|January 23, 2015
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinomaDaniela Sia, Bojan Losic, Agrin Moeini, et al.The New England Journal of Medicine|August 27, 2015
Targeting CD38 with Daratumumab Monotherapy in Multiple MyelomaHenk M Lokhorst, Torben Plesner, Jacob P Laubach, et al.Pageof 27